Nachrichten zur Surmodics Aktie

SurModics (SRDX) May Find a Bottom Soon, Heres Why You Should Buy the Stock Now

SurModics (SRDX) appears to have found support after losing some value lately, as indicated by the formation of a hammer…

Surmodics jumps 18% on acquisition by GTCR

…

Heres Why You Should Hold Surmodics (SRDX) Stock for Now

Surmodics (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.…

Surmodics, Inc. (SRDX) Q2 2024 Earnings Call Transcript

…

Heres Why You Should Hold Surmodics (SRDX) Stock for Now

Surmodics (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.…

Surmodics, Inc (SRDX) Q1 2024 Earnings Call Transcript

…

Surmodics (SRDX) New Device to Boost Its Thrombectomy Platform

Surmodics (SRDX) new addition to its Pounce Thrombectomy Platform is recommended for use in vessels with a diameter between 2…

Heres Why You Should Retain Surmodics (SRDX) Stock for Now

Surmodics (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.…

Surmodics, Inc. (SRDX) Q4 2023 Earnings Call Transcript

…

Surmodics, Inc. 2023 Q4 - Results - Earnings Call Presentation

…

Snap These 4 Top-Ranked Liquid Stocks for Solid Returns

Here are four top-performing liquid stocks, Deckers Outdoor (DECK), Surmodics (SRDX), NVIDIA (NVDA) and Sprinklr (CXM), which investors can add…

Hydrophilic Coating Market revenue to hit USD 30 Billion by 2035, says Research Nester

Leading hydrophilic coating market players include Surmodics, Inc., Hydromer Inc., Aculon Inc., Biocoat Incorporated, Harland Medical Systems, Sono-Tek Corporation, Koninklijke…

3 Reasons to Add Surmodics (SRDX) Stock to Your Portfolio

Surmodics (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.…

Sizing Up Surmodics, Inc.

…

Microcatheter Market to Hit US$ 1,259.78 Million By 2031 | Research By Consegic Business Intelligence

Consegic Business Intelligence analyzes that the microcatheter market is growing with a healthy CAGR of 5.1% during the forecast period…

Surmodics (SRDX) Q3 Earnings Top Estimates, FY23 View Up

Surmodics (SRDX) reports a solid fiscal third quarter top line on the back of robust Medical Device revenues....…

SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for SurModics (SRDX) give insight into how the company performed in the quarter ended June 2023, but…

Surmodics Non-GAAP EPS of $0.52 beats by $0.98, revenue of $52.5M beats by $14.44M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-Q SURMODICS INC For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K SURMODICS INC For: Aug 02

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K SURMODICS INC For: Jul 20

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Three Reasons to Add Surmodics (SRDX) Stock to Your Portfolio

Surmodics (SRDX) solid prospects in the thrombectomy business raise optimism about the stock....…

Why Shares of Surmodics Jumped This Week

The company gained FDA marketing approval for a drug-coated balloon that will help clear blocked arteries....…

Surmodics (SRDX) Rallies on FDA Approval for SurVeil DCB

Surmodics (SRDX) SurVeil DCB is indicated to treat percutaneous transluminal angioplasty in peripheral artery disease patients. Abbott will initiate commercialization…

Strength Seen in SurModics (SRDX): Can Its 16.1% Jump Turn into More Strength?

SurModics (SRDX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might…

Surmodics Shares Up 8% on FDA Approval for SurVeil Drug-Coated Balloon

Surmodics Shares Up 8% on FDA Approval for SurVeil Drug-Coated Balloon...…

Surmodics spikes on FDA nod for SurVeil drug coated balloon

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Surmodics Gets FDA Approval for SurVeil Drug-Coated Balloon

Surmodics Gets FDA Approval for SurVeil Drug-Coated Balloon...…

Form 8-K SURMODICS INC For: Jun 20

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Surmodics Receives FDA Clearance for Thrombectomy System

Surmodics Receives FDA Clearance for Thrombectomy System...…

Why Shares of Surmodics Soared on Tuesday

An analyst upgrade gave the stock a boost....…

Surmodics upgraded at Needham citing FDA nod for drug coated balloon

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Surmodics files for $200M mixed shelf offering

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Surmodics (SRDX) Q2 Earnings Top Estimates, FY23 View Revised

Surmodics (SRDX) reports a solid fiscal second-quarter top line on the back of robust Medical Device revenues....…

Form 10-Q SURMODICS INC For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K SURMODICS INC For: Apr 26

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Surmodics Shares Rise 11% After FDA Request for SurVeil Drug-Coated Balloon Info

Surmodics Shares Rise 11% After FDA Request for SurVeil Drug-Coated Balloon Info...…

Surmodics stock surges 10% on FDA feedback for drug-coated balloon filing

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Surmodics Gets FDA Request for Clarification of SurVeil Drug-Coated Balloon

Surmodics Gets FDA Request for Clarification of SurVeil Drug-Coated Balloon...…

SurModics (SRDX) Moves 5.4% Higher: Will This Strength Last?

SurModics (SRDX) saw its shares surge in the last session with trading volume being higher than average. The latest trend…

Form 8-K SURMODICS INC For: Mar 15

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

SurModics (SRDX) Down 37.2% Since Last Earnings Report: Can It Rebound?

SurModics (SRDX) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surmodics, Inc. - SRDX

NEW YORK, Feb. 22, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Surmodics, Inc. ("Surmodics"…

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX

NEW YORK, Feb. 21, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Surmodics, Inc. - SRDX

New York, New York--(Newsfile Corp. - February 18, 2023) - Pomerantz LLP is investigating claims on behalf of investors of…

ROSEN, Global Investor Counsel, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX

New York, New York--(Newsfile Corp. - February 17, 2023) - WHY: Rosen Law Firm, a global investor rights law firm,…

Surmodics Investigated by Block & Leviton for Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Boston, Massachusetts--(Newsfile Corp. - February 15, 2023) - Block & Leviton is investigating Surmodics, Inc. (NASDAQ: SRDX) for potential securities…

Surmodics downgraded at Needham on uncertainty over drug-coated balloon

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Surmodics downgraded to hold from buy at Needham

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

SRDX INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX

NEW YORK, Feb. 8, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation…